Muscle loss is a meaningful risk during rapid weight loss, particularly at higher doses
We added a Flag-tagged GCP16/Golga7 construct to the SwissKASH system for zDHHC5 and 9, and applied it to Go-Nt 7 and MGNC-Nt 7
A few things are important to note in these studies one is the overwhelming majority of people are experiencing what we call clinically meaningful treatment response, or weight loss of at least 5%, Jamy D
As the science continues to evolve, were seeing that these benefits may extend to people who dont necessarily need to lose weight, and thats opened up an interesting conversation about why people are microdosing GLP-1 medications
BMJ Meta-Analysis (2014): Among 353,639 patients, pooled odds ratios showed no excess risk of pancreatitis for either GLP-1 agonists or DPP-4 inhibitors
Treating earlier risks chasing a moving target, and treating later means you spend months looking older than you should